Philadelphia chromosome-negative myeloproliferative neoplasm with a novel platelet-derived growth factor receptor-β rearrangement responsive to imatinib - PubMed

Affiliations

• PMID: 22331939
• DOI: 10.1200/JCO.2011.39.0377

Case Reports

Philadelphia chromosome-negative myeloproliferative neoplasm with a novel platelet-derived growth factor receptor-β rearrangement responsive to imatinib

Dennis Cornfield et al. J Clin Oncol. 2012.

Similar articles

• KANK1, a candidate tumor suppressor gene, is fused to PDGFRB in an imatinib-responsive myeloid neoplasm with severe thrombocythemia.

  Medves S, Duhoux FP, Ferrant A, Toffalini F, Ameye G, Libouton JM, Poirel HA, Demoulin JB. Medves S, et al. Leukemia. 2010 May;24(5):1052-5. doi: 10.1038/leu.2010.13. Epub 2010 Feb 18. Leukemia. 2010. PMID: 20164854 No abstract available.

• Fusion of PRKG2 and SPTBN1 to the platelet-derived growth factor receptor beta gene (PDGFRB) in imatinib-responsive atypical myeloproliferative disorders.

  Gallagher G, Horsman DE, Tsang P, Forrest DL. Gallagher G, et al. Cancer Genet Cytogenet. 2008 Feb;181(1):46-51. doi: 10.1016/j.cancergencyto.2007.10.021. Cancer Genet Cytogenet. 2008. PMID: 18262053

• Fusion of PDGFRB to two distinct loci at 3p21 and a third at 12q13 in imatinib-responsive myeloproliferative neoplasms.

  Hidalgo-Curtis C, Apperley JF, Stark A, Jeng M, Gotlib J, Chase A, Cross NC, Grand FH. Hidalgo-Curtis C, et al. Br J Haematol. 2010 Jan;148(2):268-73. doi: 10.1111/j.1365-2141.2009.07955.x. Br J Haematol. 2010. PMID: 20085582

• Beyond chronic myelogenous leukemia: potential role for imatinib in Philadelphia-negative myeloproliferative disorders.

  Cortes J, Kantarjian H. Cortes J, et al. Cancer. 2004 May 15;100(10):2064-78. doi: 10.1002/cncr.20211. Cancer. 2004. PMID: 15139047 Review.

• Translocation t(12;13)(p13;q14) in a patient with imatinib-sensitive MDS/MPD associated with resistance to treatment: review of the literature.

  Diamantopoulos PT, Athanasiadou A, Papakostas E, Gratsias N, Georgiou G, Mantzourani M, Andreopoulos G, Panagiotidis P, Aessopos A, Meletis J, Viniou N. Diamantopoulos PT, et al. Anticancer Drugs. 2011 Oct;22(9):944-7. doi: 10.1097/CAD.0b013e3283486ca4. Anticancer Drugs. 2011. PMID: 21712707 Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Ovid Technologies, Inc.